 Pseudomonas Infections
"Pseudomonas Infections" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Infections with bacteria of the genus PSEUDOMONAS.
| Descriptor ID |
D011552
|
| MeSH Number(s) |
C01.252.400.739
|
| Concept/Terms |
Pseudomonas Infections- Pseudomonas Infections
- Infections, Pseudomonas
- Infection, Pseudomonas
- Pseudomonas Infection
|
Below are MeSH descriptors whose meaning is more general than "Pseudomonas Infections".
Below are MeSH descriptors whose meaning is more specific than "Pseudomonas Infections".
This graph shows the total number of publications written about "Pseudomonas Infections" by people in this website by year, and whether "Pseudomonas Infections" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 | | 1996 | 1 | 0 | 1 | | 1997 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 2001 | 0 | 2 | 2 | | 2002 | 4 | 1 | 5 | | 2003 | 1 | 1 | 2 | | 2004 | 3 | 4 | 7 | | 2005 | 2 | 0 | 2 | | 2006 | 0 | 3 | 3 | | 2007 | 4 | 1 | 5 | | 2008 | 2 | 0 | 2 | | 2009 | 3 | 3 | 6 | | 2010 | 3 | 0 | 3 | | 2011 | 2 | 4 | 6 | | 2012 | 2 | 1 | 3 | | 2013 | 5 | 1 | 6 | | 2014 | 7 | 4 | 11 | | 2015 | 6 | 5 | 11 | | 2016 | 5 | 1 | 6 | | 2017 | 3 | 1 | 4 | | 2018 | 1 | 1 | 2 | | 2019 | 12 | 1 | 13 | | 2020 | 2 | 3 | 5 | | 2021 | 5 | 1 | 6 | | 2022 | 4 | 1 | 5 | | 2023 | 3 | 0 | 3 | | 2024 | 2 | 3 | 5 | | 2025 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Pseudomonas Infections" by people in Profiles.
-
Fireizen Y, Ahmed M, Vigers T, Akong K, Ryu J, Hahn A, Fanous H, Koumbourlis A, Tirakitsoontorn P, Arrieta A, Burgener EB, Koff J, Cogen JD, Bouzek DC, Hanley E, Keck A, Stout D, Bradley J, Sagel SD. Changing Epidemiology of Pediatric Pulmonary Exacerbations in Cystic Fibrosis. Pediatr Pulmonol. 2025 Mar; 60(3):e71019.
-
Escobedo HD, Zawadzki N, Till JKA, Vazquez-Torres A, Wang G, Simberg D, Orlicky DJ, Johnson J, Guess MK, Nair DP, Schurr MJ. Nanogels conjugated with cell-penetrating peptide as drug delivery vehicle for treating urinary tract infections. Nanomedicine. 2025 Apr; 65:102812.
-
Jain R, Peng G, Lee M, Keller A, Cosmich S, Reddy S, West NE, Kazmerski TM, Goralski JL, Flume PA, Roe AH, Hadjiliadis D, Uluer A, Mody S, Ladores S, Taylor-Cousar JL. Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Maternal Outcomes During and After Pregnancy. Chest. 2025 Feb; 167(2):348-361.
-
Calo CJ, Patil T, Palizzi M, Wheeler N, Hind LE. Collagen concentration regulates neutrophil extravasation and migration in response to infection in an endothelium dependent manner. Front Immunol. 2024; 15:1405364.
-
Mueller SW, Molina KC, Blass B, Gibson C, Kohler AD, Krsak M, Wiktor AJ. Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa. J Burn Care Res. 2024 05 06; 45(3):808-810.
-
Neve RL, Giedraitis E, Akbari MS, Cohen S, Phelan VV. Secondary metabolite profiling of Pseudomonas aeruginosa isolates reveals rare genomic traits. mSystems. 2024 May 16; 9(5):e0033924.
-
Neff SL, Doing G, Reiter T, Hampton TH, Greene CS, Hogan DA. Pseudomonas aeruginosa transcriptome analysis of metal restriction in ex vivo cystic fibrosis sputum. Microbiol Spectr. 2024 Apr 02; 12(4):e0315723.
-
Kim JS, Montesi SB, Adegunsoye A, Humphries SM, Salisbury ML, Hariri LP, Kropski JA, Richeldi L, Wells AU, Walsh S, Jenkins RG, Rosas I, Noth I, Hunninghake GM, Martinez FJ, Podolanczuk AJ. Approach to Clinical Trials for the Prevention of Pulmonary Fibrosis. Ann Am Thorac Soc. 2023 12; 20(12):1683-1693.
-
Wagner BD, Zemanick ET, Sagel SD, Robertson CE, Stevens MJ, Mayer-Hamblett N, Retsch-Bogart G, Ramsey BW, Harris JK. Limited effects of azithromycin on the oropharyngeal microbiome in children with CF and early pseudomonas infection. BMC Microbiol. 2023 10 27; 23(1):312.
-
Baty JJ, Stoner SN, McDaniel MS, Huffines JT, Edmonds SE, Evans NJ, Novak L, Scoffield JA. An oral commensal attenuates Pseudomonas aeruginosa-induced airway inflammation and modulates nitrite flux in respiratory epithelium. Microbiol Spectr. 2023 Dec 12; 11(6):e0219823.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|